Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/29/2025

Management of Intracranial Pressure in Bacterial Meningitis

Fluid and Hemodynamic Management

Seizure Management

Intracranial Pressure Monitoring

Evidence Quality Summary

All patient‑specific details have been generalized to preserve anonymity and focus on actionable guidance.

Bactrim and Intracranial Pressure: Clinical Considerations

Clinical Presentations and Diagnostic Workup

  • Headache is the predominant symptom, occurring in nearly 90% of IIH cases, according to the American College of Physicians, and is often accompanied by visual disturbances, including transient visual obscurations, blurred vision, or diplopia, which are critical for early diagnosis 4
  • Papilledema on fundoscopic examination is the defining clinical finding, and pulsatile tinnitus may also be present, highlighting the need for thorough neurological examination 4
  • Young women of childbearing age who are overweight represent the classic demographic for IIH, and symptoms typically develop within a specific timeframe, emphasizing the importance of demographic consideration in diagnosis 4
  • MRI brain with and without contrast is the most appropriate initial imaging study, as it is more sensitive than CT for detecting secondary signs of increased ICP, and should include MR venography (MRV) to evaluate for venous outflow obstruction or stenosis, according to the American Academy of Neurology 4
  • Coronal fat-saturated T2-weighted sequences of the orbits should be obtained to evaluate for dilated optic nerve sheaths, which is a key finding in IIH diagnosis 4

Diagnostic Criteria and Management

  • Opening pressure >250 mm H₂O confirms the diagnosis of IIH, and CSF analysis must show normal cell count, glucose, and protein to distinguish from infectious meningitis, as recommended by the Infectious Diseases Society of America 4
  • If opening pressure is ≥250 mm H₂O, remove CSF to reduce pressure to 50% of opening pressure or 200 mm H₂O, whichever is greater, which is a critical step in managing elevated ICP 4
  • Therapeutic lumbar puncture with removal of 20-30 mL of CSF provides immediate symptom relief, and serial lumbar punctures may be needed daily if pressure remains elevated, highlighting the importance of prompt intervention 4, 5
  • Lumbar drain placement requires inpatient monitoring if ICP remains persistently elevated despite initial interventions, and neurosurgical consultation for ventriculoperitoneal shunt consideration if medical therapy fails, as recommended by the American Association of Neurological Surgeons 4, 5

Management of Elevated ICP in Infectious Meningitis

  • Percutaneous lumbar drainage is the principal intervention for reducing elevated ICP in cryptococcal meningitis, with daily lumbar punctures to maintain normal CSF opening pressure, according to the Centers for Disease Control and Prevention 6, 7
  • Lumbar drain or ventriculoperitoneal shunt may be required for persistent elevation, and mannitol, acetaminophen, hypertonic saline, and glycerol are NOT recommended for bacterial meningitis-related elevated ICP, as stated by the European Society of Clinical Microbiology and Infectious Diseases 6, 8, 9, 7, 10

Critical Considerations

  • Do not continue Bactrim if drug-induced IIH is suspected—the risk of permanent vision loss outweighs antimicrobial benefits, and do not use osmotic agents (mannitol, glycerol, hypertonic saline) routinely for ICP management in meningitis, as they lack proven benefit and may cause harm, as recommended by the American College of Physicians and the European Society of Clinical Microbiology and Infectious Diseases 8, 9, 10
  • Do not delay lumbar puncture for neuroimaging unless focal neurological signs or obtundation suggest mass lesion, and do not assume normal imaging excludes elevated ICP—lumbar puncture with opening pressure measurement is required for diagnosis, according to the American Academy of Neurology 4, 6, 7